Read More Pharma Industry News ZULRESSO postpartum depression drug set to be launched in US by Sage Therapeutics CNS biopharma company Sage Therapeutics is all set to commercially launch its ZULRESSO (brexanolone) injection in the US… bypharmanewsdailyJune 15, 2019